Retrospective financial analysis of a herpes zoster vaccination program from an independent community pharmacy perspective.
OBJECTIVE
To determine the net financial gain or loss for herpes zoster vaccination services provided to patients from the perspective of an independent community pharmacy.


METHODS
Retrospective review of pharmacy records over the program's initial 11-month period.


METHODS
Independent community pharmacy in Iowa City, IA.


METHODS
Patients received immunization with the herpes zoster vaccine from a certified pharmacist.


METHODS
Herpes zoster vaccination services were provided to the patient and documented by the pharmacist.


METHODS
Net financial gains or losses were calculated for the herpes zoster vaccination program. Sensitivity analyses were based on costs that might be incurred during program start-up.


RESULTS
478 patients received zoster vaccination services over the initial 11-month period. A net financial gain for the herpes zoster vaccination program was achieved, with a net profit of $15.02, or 8.15%, per vaccination.


CONCLUSIONS
Revenues for this vaccination program exceeded its costs from the independent community pharmacy perspective.
Wood
Heidi M
HM
College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA.
McDonough
Randal P
RP
Doucette
William R
WR
D000368:Aged; D000369:Aged, 80 and over; D003157:Community Pharmacy Services / Q000191:economics* / Q000458:organization & administration; D003362:Cost-Benefit Analysis; D005260:Female; D006562:Herpes Zoster / Q000517:prevention & control*; D053061:Herpes Zoster Vaccine / Q000008:administration & dosage / Q000191:economics*; D006801:Humans; D017589:Immunization Programs / Q000191:economics* / Q000458:organization & administration; D007484:Iowa; D008297:Male; D010595:Pharmacists / Q000458:organization & administration; D024382:Professional Role; D012189:Retrospective Studies
D053061:Herpes Zoster Vaccine